The risk for HCQ-associated retinopathy increases over time among patients with rheumatic diseases, particularly at higher doses and with prolonged exposure.
That’s what the autoimmune disease lupus does, 1 and when it strikes, it can cause significant symptoms, including extreme ...
Choose a protein powder that matches your goals and dietary needs. Prioritize low-sugar, independently-tested options with ...
Everyday Health on MSN
Can GLP-1 drugs for obesity and diabetes also treat other diseases?
Researchers are exploring drugs like Ozempic, Mounjaro, and Wegovy to treat or prevent a range of conditions, including ...
Ad hoc announcement pursuant to Art. 53 LR A conference call will be held on April 28, 2026, at 14:00 CEST / 13:00 BST / 08:00 EDT. Details are at the end of this news release AGAMREE delivers ...
Ad hoc announcement pursuant to Art. 53 LRA conference call will be held on April 28, 2026, at 14:00 CEST / 13:00 BST / 08:00 EDT. Details are at ...
People with rheumatoid arthritis and seasonal allergies can take steps to improve symptoms. Learn about limiting pollen ...
A major European study, MethMax, has begun to test whether optimizing methotrexate dosing and administration routes can improve remission rates in active rheumatoid arthritis. The trial will compare ...
Interim results from two investigator-initiated trials revealed insights into the role of injectables to address the ...
Beyond standard risk scores, the guideline highlights key risk enhancers—including lipoprotein(a), inflammation markers, and ...
The field of obesity management has been significantly advanced by the introduction of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), which have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results